Hengrui Therapeutics, Inc.   Report issue

Founded: Lianyungang China (1970)

Organization Overview

First Clinical Trial
2009
NCT01762280
First Marketed Drug
2011
irinotecan (Camptosar)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Guangdong Hengrui Pharmaceutical Co., Ltd | HengRui YuanZheng Bio-Technology Co.,Ltd. | JIANGSU HENGRUI MED | Jiangsu HengRui Medicine Co. | Jiangsu HengRui Medicine Co., Ltd. | Jiangsu Hengrui Pharmaceutical Co., Ltd. | Jiangsu Hengrui Pharmaceutical Co., LTD | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | SHANGHAI HENGRUI | Shanghai Hengrui Pharmaceutical Co., Ltd. | Yue Han | Zhigang Li